# Brepocitinib yields improvements in cutaneous sarcoidosis

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-brepocitinib-yields-cutaneous-sarcoidosis.html) · 2026-11-18 · Medicine
Page: https://themorning.science/story/brepocitinib-yields-improvements-in-cutaneous-sarcoidosis-a7245e4050dabbd0
Kind: research · Impact: medium

## In brief

- A study in JAMA Dermatology reports that brepocitinib is associated with dose-dependent, clinically meaningful improvements in cutaneous sarcoidosis.
- The study was published online to coincide with the annual meeting of the American College of Rheumatology.

## Why it matters

The findings offer a trial-based signal that an investigational drug may improve skin manifestations of sarcoidosis, which matters to clinicians and researchers working on inflammatory skin and systemic disease.

## Coverage

- [Brepocitinib yields improvements in cutaneous sarcoidosis](https://medicalxpress.com/news/2026-11-brepocitinib-yields-cutaneous-sarcoidosis.html) — Medical Xpress - latest medical and health news stories, 2026-11-18

Tags: sarcoidosis, brepocitinib, dermatology, clinical trial, rheumatology

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
